GCNTFinancing•businesswire•
GeneCentric Announces Series C Financing to Advance Novel Liquid Biopsy Platform for Precision Oncology
Sentiment:Positive (80)
Summary
DURHAM, N.C.--(BUSINESS WIRE)-- #GeneCentric--GeneCentric Announces $8 Million Series C Financing to Advance Novel GenomicsNext Liquid Biopsy Platform for Precision Oncology
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on June 18, 2025 by businesswire